Imeglimin is an oxidative phosphorylation blocker that acts to inhibit hepatic gluconeogenesis, increase muscle glucose uptake, and restore normal insulin secretion. Imeglimin is being developed as an oral anti-diabetic. Various research protocols are being known through various scientists. Early studies showed that imeglimin is as effective as metformin in regulating glycaemic control. (last updated :2/19/2016).

Product information

CAS Number: 775351-65-0

Molecular Weight: 155.20

Formula: C6H13N5

Synonym:

EMD 387008

EMD387008

EMD-387008

Chemical Name: (6R)-N2,N2,6-trimethyl-3,6-dihydro-1,3,5-triazine-2,4-diamine

Smiles: C[C@H]1N=C(NC(N)=N1)N(C)C

InChiKey: GFICWFZTBXUVIG-SCSAIBSYSA-N

InChi: InChI=1S/C6H13N5/c1-4-8-5(7)10-6(9-4)11(2)3/h4H,1-3H3,(H3,7,8,9,10)/t4-/m1/s1

Technical Data

Appearance: Solid Power

Purity: ≥98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis

Storage Condition: Dry, dark and -20 ^oC for 1 year or refer to the Certificate of Analysis.

Shelf Life: ≥12 months if stored properly.

Stock Solution Storage: 0 - 4 ^oC for 1 month or refer to the Certificate of Analysis.

Drug Formulation: To be determined

HS Tariff Code: 382200

Products are for research use only. Not for human use.